Offline dengan aplikasi Player FM !
Stem Cells & Drug Discovery with Dr. Matthias Steger
Manage episode 445729487 series 3609046
Dr. Matthias Steger is co-Founder and CEO of Endogena Therapeutics, a biotech company with a novel drug discovery concept based on selective regulation of endogenous stem cells to repair and regenerate organs and tissues.
Matthias worked for 22 years in the pharmaceutical-biotech industry. Prior to Endogena, he worked as Global Head of Research & Technology Partnering, at Roche, setting up and managing > 50 collaborations and acquisitions for novel drug modalities, new drug discovery technologies, as well as enabling technologies, such as translational models, biomarkers, and drug delivery/formulation. Matthias has also lead and implemented various corporate strategies exploring novel drug discovery approaches, and as such has initiated and built up Roche’s stem cell research.
In addition, Matthias worked as an independent consultant for various biotech companies, academic institutes and venture capital firms, exploring novel drug discovery – and partnering/investment strategies. He also has prior entrepreneurial experience by building up a pioneering orphan GPCR drug discovery company, which lead to a successful acquisition. Matthias started his career in research, as a medicinal chemist at Roche, exploring novel platforms and drug design approaches, as well as traditional drug discovery programs. He also gained a financial perspective of the industry as an investment banking analyst at Kepler Equities.
He served as an executive board member of the Alliance for Regenerative Medicine (ARM), as well as the chair of the industry committee of the International Society of Stem Cell Research (ISSCR). Matthias has a Diploma in Organic Chemistry (University of Zürich, Switzerland), and a PhD in Medicinal Chemistry from the University of Sussex, UK, as well as an MBA from HSG (St. Gallen, Switzerland).
16 episode
Manage episode 445729487 series 3609046
Dr. Matthias Steger is co-Founder and CEO of Endogena Therapeutics, a biotech company with a novel drug discovery concept based on selective regulation of endogenous stem cells to repair and regenerate organs and tissues.
Matthias worked for 22 years in the pharmaceutical-biotech industry. Prior to Endogena, he worked as Global Head of Research & Technology Partnering, at Roche, setting up and managing > 50 collaborations and acquisitions for novel drug modalities, new drug discovery technologies, as well as enabling technologies, such as translational models, biomarkers, and drug delivery/formulation. Matthias has also lead and implemented various corporate strategies exploring novel drug discovery approaches, and as such has initiated and built up Roche’s stem cell research.
In addition, Matthias worked as an independent consultant for various biotech companies, academic institutes and venture capital firms, exploring novel drug discovery – and partnering/investment strategies. He also has prior entrepreneurial experience by building up a pioneering orphan GPCR drug discovery company, which lead to a successful acquisition. Matthias started his career in research, as a medicinal chemist at Roche, exploring novel platforms and drug design approaches, as well as traditional drug discovery programs. He also gained a financial perspective of the industry as an investment banking analyst at Kepler Equities.
He served as an executive board member of the Alliance for Regenerative Medicine (ARM), as well as the chair of the industry committee of the International Society of Stem Cell Research (ISSCR). Matthias has a Diploma in Organic Chemistry (University of Zürich, Switzerland), and a PhD in Medicinal Chemistry from the University of Sussex, UK, as well as an MBA from HSG (St. Gallen, Switzerland).
16 episode
Semua episode
×1 Journey into Leadership: A conversation with Sarah Mardle 44:36
1 Exploring Quality Leadership and Systems with Heather Wells 36:01
1 The Next Generation of Cell & Gene Therapies 55:48
1 The Cultivated Meat Industry and LGBTQIA+ in Biotech with Mirasbek Kuterbekov 34:24
1 Clinical in Switzerland: Start-up Bio vs. Pharma 52:40
1 Tackling the Gender Imbalance in Engineering with Lorraine Liu 18:50
1 Neurodiversity in Life Sciences with Christy Mazzarisi 27:37
1 Developing a Career in Quality within Life Sciences with Katie Terry, Greg Whitehead and Jared Auclair 51:30
1 The Journey of a HealthTech Start-up with Dr Hemmel Amrania 54:57
1 Project Leadership during a pandemic – building a state of the art facility in uncertain times with Andreas Zander 44:23
1 Stem Cells & Drug Discovery with Dr. Matthias Steger 21:11
1 Digital Solutions in Healthcare with Baris Ersezer 22:51
1 Leading with Empathy with Michael Potts 48:10
1 Pandemic Challenges & Agile Processes in Regulatory Affairs with Florin Muraru 25:54
1 AI/Machine Learning in Pharmaceutical with Sion Wyn 37:15
Selamat datang di Player FM!
Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.